The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

Clinical trial NCT06285279 · RECRUITING

Trial details

NCT number: NCT06285279
Sponsor: Nanjing University School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Nephritis ANCA-associated Vasculitis Membranous Nephropathy - PLA2R Induced IgG4-Related Diseases

Start date: 2024-03-04
Primary completion: 2026-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.